REVELATION BIOSCIENCES, INC. Machinery and Equipment, Gross
REVELATION BIOSCIENCES, INC. (REVB) had Machinery and Equipment, Gross of $252.70 thousand as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent › Property, Plant, and Equipment, after Accumulated Depreciation, Depletion, and Amortization › Property, Plant, and Equipment, before Accumulated Depreciation, Depletion, and Amortization
us-gaap:MachineryAndEquipmentGross · last filed 2026-08-06
- 2026-06-30: Machinery and Equipment, Gross $252.70K.
- 2026-03-31: Machinery and Equipment, Gross $246.91K.
- 2025-12-31: Machinery and Equipment, Gross $117.06K.
- 2024-12-31: Machinery and Equipment, Gross $151.13K.
| Period end | Machinery and Equipment, Gross |
|---|---|
| 2026-06-30 | $252.70K 10-Q · filed 2026-08-06 |
| 2026-03-31 | $246.91K 10-Q · filed 2026-05-07 |
| 2025-12-31 | $117.06K 10-Q · filed 2026-08-06 |
| 2024-12-31 | $151.13K 10-K · filed 2026-02-26 |
| 2024-09-30 | $168.82K 10-Q · filed 2024-11-08 |
| 2024-06-30 | $151.13K 10-Q/A · filed 2024-09-23 |
| 2024-03-31 | $151.13K 10-Q/A · filed 2024-09-23 |
| 2023-12-31 | $131.96K 10-K · filed 2025-03-06 |
| 2023-09-30 | $131.96K 10-Q · filed 2023-11-09 |
| 2023-06-30 | $131.96K 10-Q · filed 2023-08-11 |
| 2023-03-31 | $131.96K 10-Q · filed 2023-05-22 |
| 2022-12-31 | $131.96K 10-K/A · filed 2024-09-23 |
| 2022-09-30 | $131.96K 10-Q · filed 2022-11-10 |
| 2022-06-30 | $131.96K 10-Q · filed 2022-08-15 |
| 2022-03-31 | $131.96K 10-Q · filed 2022-05-16 |
| 2021-12-31 | $131.96K 10-K · filed 2023-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |